PATH | VRL
Menu

Find resources

Total results with these characteristics: 38

Disease: Group B Streptococcus (GBS)

Page 1 of 2
Antibody-Independent Classical Pathway-Mediated Opsonophagocytosis of Type Ia, Group B Streptococcus

This article, published in The Journal of Clinical Investigation, elborates on experiements that indicate substances other than the exposed surface of the type Ia capsular polysaccharide initiate classical pathway-mediated opsonophagocytosis of …

Author: Baker CJ, Edwards MS, Webb BJ, Kasper DL

Publication date: 1982

Center for Vaccine Innovation and Access

This website provides information about the work of PATH’s Center for Vaccine Innovation and Access, which brings together expertise across every stage of vaccine research, development, and introduction to make lifesaving vaccines globally …

Author: PATH

Considerations for a Phase III Trial to Evaluate a Group B Streptococcus Polysaccharide-Protein Conjugate Vaccine in Pregnant Women for the Prevention of Early- and Late-Onset Invasive Disease in Young Infants

This article, published in Vaccine, discusses the global disease burden of group B Streptococcus (GBS) and strategies to combat the disease. The authors argue that vaccination is a promising strategy, particularly in low-income countries where …

Author: Madhi SA, Dangor Z, Heath PT, et al.

Publication date: 2013

Cost-Effectiveness of a Potential Group B Streptococcal Vaccine Program for Pregnant Women in South Africa

No licensed vaccine for group B Streptococcus (GBS) currently exists, but a polysaccharide-protein conjugate vaccine candidate is currently in trials. This article, published in Vaccine, reports the results of a study that evaluated the potential …

Author: Kim S-Y, Russell LB, Park J, et al.

Publication date: 2014

Disease Burden of Group B Streptococcus Among Infants in Sub-Saharan Africa: A Systematic Literature Review and Meta-Analysis

Group B streptococcus (GBS) is a leading neonatal sepsis pathogen, and investment in disease prevention, such as maternal vaccination, requires evidence of disease burden. This article, published in The Pediatric Infectious Disease Journal, reports …

Author: Sinha A, Russell LB, Tomczyk S, et al.

Publication date: 2016

Early-Onset Neonatal Sepsis

This article, published in Clinical Microbiology Reviews, discusses early-onset sepsis in neonates, particularly in pre-term infants. It notes that group B Streptococcus (GBS) is the most common cause and outlines current efforts to combat GBS, …

Author: Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD

Publication date: 2014

Estimating the Full Public Health Value of Vaccination

This conference report, published in Vaccine, builds upon a discussion in the public health community on how to assess and incorporate, in addition to safety and measures of protective efficacy, the full public health value (FPHV) of preventive …

Author: Gessner BD, Kaslow D, Louis J, et al.

Publication date: 2017

GBS Public Awareness, Advocacy, and Prevention—What’s Working, What’s Not and Why We Need a Maternal GBS Vaccine

This article, published in Vaccine, provides an overview of group B Streptococcus (GBS) disease burden and awareness-raising activities, and outlines current prevention and screening strategies. The authors argue that vaccination, once available, …

Author: Burns G, Plumb J

Publication date: 2013

Group B Strep (GBS)

This web page provides general information about group B Streptococcus (GBS), including resources for clinicians and pregnant women, information on surveillance efforts, prevention guidelines, and links to publications about GBS.

Author: US Centers for Disease Control and Prevention

Group B Strep International

This website aims to promote international awareness and prevention of group B Streptococcus (GBS) disease in babies before birth and through early infancy. It provides general information and resources on GBS in a variety of languages for both the …

Author: Group B Strep International

Group B Strep Support: Preventing Life-Threatening GBS Infection in Newborn Babies

This website provides up-to-date and evidence-based information on group B Streptococcus (GBS) to families and their health care professionals, and support to affected families. The organization also advocates for the elimination of GBS in infants …

Author: Group B Strep Support

Group B Strep: What You Need to Know

This fact sheet provides answers to frequently asked questions for pregnant women regarding group B Streptococcus (GBS) disease in newborns and how to prevent passing GBS on to babies during labor.

Author: US Centers for Disease Control and Prevention

Publication date: 2014

Group B Streptococcal Conjugate Vaccines

This article, published in Archives of Disease in Childhood, provides an update on the status of group B Streptococcus (GBS) polysaccharide-protein conjuate vaccines. It presents the rationale for the development of GBS conjugate vaccines, the …

Author: Baker CJ, Edwards MS

Publication date: 2003

Group B Streptococcal Vaccine for Resource-Poor Countries

This article, published in The Lancet, discusses maternal immunization's potential to protect neonates from infectious diseases such as group B Streptococcus. Neonatal deaths, which mostly occur in resource-poor countries during the first week of …

Author: Shrag SJ

Publication date: 2011

Group B Streptococcus Vaccine: State of the Art

This article, published in Therapeutic Advances in Vaccines, provides an overview of the burden of invasive disease caused by group B Streptococcus (GBS) in infants and adults, and highlights strategies for the development of an effective vaccine …

Author: Nuccitelli A, Rinaudo CD, Maione D

Publication date: 2015

Immune Response of Healthy Women to 2 Different Group B Streptococcal Type V Capsular Polysaccharide-Protein Conjugate Vaccines

This article, published in the Journal of Infectious Diseases, reports the results of a study to examine the safety and immunogenicity of two group B Streptococcus (GBS) type V capsular polysaccharide-protein conjugate vaccines. The authors found …

Author: Baker CJ, Paoletti LC, Rench MA, Guttormsen H-K, Edwards MS, Kasper DL

Publication date: 2004

Immune Response to Type III Group B Streptococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine

This article, published in The Journal of Clinical Investigation, reports the results of a study that examined a capsular polysaccharide-protein conjugate vaccine against group B Streptococccus. The authors found that the vaccine candidate was …

Author: Kasper DL, Paoletti LC, Wessels MR, et al.

Publication date: 1996

Jordan Report: Accelerated Development of Vaccines 2012

This comprehensive report includes expert articles on a variety of vaccine-related topics and updates on vaccine research for specific infectious diseases, such as influenza, malaria, respiratory syncytial virus, and rotavirus.

Author: US National Institute of Allergy and Infectious Diseases

Publication date: 2012

Maternal Immunization Safety Monitoring in Low- and Middle-Income Countries: A Roadmap for Program Development

Maternal immunization holds the promise of further reducing morbidity and mortality among pregnant women and infants, particularly in low- and middle-income countries (LMICs) where there is the greatest burden of vaccine-preventable disease. This …

Author: Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)

Publication date: 2017

A Maternal Vaccine Against Group B Streptococcus: Past, Present, and Future

This review article, published in Vaccine, explores the history of the design of maternal vaccines against group B Streptococcus (GBS). GBS is a major cause of morbidity and mortality among neonates. The article notes that though there have been …

Author: Chen VL, Avci FY, Kasper DL

Publication date: 2013

Page 1 of 2